2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Bladder Neoplasm: new trials by email Literature Review of Bladder Neoplasm trials Research Report on Bladder Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm | Phase 3 | Terminated | Medical Enterprises Ltd. | 5 | 2019-04-04 | 2020-04-15 |
| Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer EN3348, Mitomycin C - Bladder Neoplasm, Neoplasm Recurrence, Local | Phase 3 | Terminated | Bioniche Life Sciences Inc. | 84 | 2010-11-01 | 2017-08-24 |
Urinary Bladder Neoplasms (2) · Carcinoma in Situ (1) · Carcinoma, Transitional Cell (1) · Disease (1) · Mycobacterium Infections (1) · Neoplasm Recurrence, Local (1) · Neoplasms (1) · Neoplasms by Site (1) · Urinary Bladder Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Carcinoma (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Mitomycin (2)
Bioniche Life Sciences Inc. (1) · Medical Enterprises Ltd. (1)
United States (2) · Canada (1) · Germany (1) · Netherlands (1) · Poland (1) · United Kingdom (1)